
Natural Language Processing (NLP) Software
Developer of disease-specific simulation models designed to replace animal drug testing by using artificial intelligence. The company's models increase human life expectancy through intelligence driven biosystem simulations to truly personalize patient treatment, enabling pharmaceutical scientists to improve the accuracy and efficiency of drug development and make personalized health care a reality.
- Revenue
- $3M
- Customers
- -
- Year founded
- 2017
- Funding
- $21.7M
- Team size
- 26
- Location
- United States











